(IBOT) Robotics - Overview
Etf: Industrial Automation, Semiconductor Equipment, Machine Vision, Motion Control
Dividends
| Dividend Yield | 0.38% |
| Yield on Cost 5y | 0.62% |
| Yield CAGR 5y | -50.55% |
| Payout Consistency | 79.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Relative Tail Risk | 0.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 18.42 |
| Character TTM | |
|---|---|
| Beta | 1.160 |
| Beta Downside | 1.113 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.39% |
| CAGR/Max DD | 0.91 |
Description: IBOT Robotics December 29, 2025
The VanEck Robotics ETF (NASDAQ: IBOT) is a U.S.-based technology-focused ETF that allocates at least 80 % of its assets to equities of companies operating in the robotics sector, including global depositary receipts. Its portfolio is classified as non-diversified, meaning concentration risk is higher than in broadly diversified funds.
Recent industry data suggest the global robotics market is expanding at a compound annual growth rate (CAGR) of roughly 12 % through 2028, driven by accelerating automation in manufacturing, logistics, and healthcare. In 2023, worldwide robot installations reached an estimated 1.9 million units, pushing total market revenue above $120 billion-a level that supports continued demand for the ETF’s underlying holdings.
Key economic drivers for the sector include tightening labor markets, rising wages, and the integration of artificial-intelligence capabilities that enhance robot productivity. Companies that secure long-term contracts for collaborative robots (cobots) or autonomous mobile robots (AMRs) tend to exhibit higher revenue growth, which can translate into stronger ETF performance.
Given the fund’s concentration in a rapidly evolving niche, investors should monitor both the macro-trend of automation spending and company-specific metrics such as order backlogs and R&D intensity to assess risk-adjusted returns.
For a deeper, data-rich perspective on IBOT’s valuation dynamics, consider exploring the analytics platform ValueRay.
What is the price of IBOT shares?
Over the past week, the price has changed by +1.81%, over one month by +4.70%, over three months by +13.39% and over the past year by +35.55%.
Is IBOT a buy, sell or hold?
What are the forecasts/targets for the IBOT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 67.2 | 15.8% |
IBOT Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 42.7m USD (42.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 42.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 42.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.19% (E(42.7m)/V(42.7m) * Re(10.19%) + (debt-free company))
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)